🇺🇸 FDA
Pipeline program

Pelareorep

REO 027

Phase 1 mab terminated

Quick answer

Pelareorep for Breast Cancer is a Phase 1 program (mab) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ONCOLYTICS BIOTECH INC
Indication
Breast Cancer
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials